Latest On Halozyme Therapeutics, Inc (HALO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-10 16:28 EST | News | Halozyme gains as Piper Sandler upgrades despite Q1 miss | N/A |  |
| 2023-05-10 03:24 EST | News | Halozyme Therapeutics Non-GAAP EPS of $0.47 misses by $0.01, revenue of $162.14M misses by $13.38M | N/A | |
| 2023-05-10 03:24 EST | News | Halozyme Therapeutics, Inc. (HALO) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 00:27 EST | News | Halozyme Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-04-12 18:00 EST | News | Halozyme's ENHANZE Technology Is The Future Of Biologics Delivery | N/A | |
| 2023-03-16 18:38 EST | News | Hot Stocks: PATH, SIG, PD rises on earnings; INTC, QCOM, SWKS upgraded at Susquehanna, FRC, HALO ESPR slide | N/A | |
| 2023-03-16 18:38 EST | News | Medicare publishes initial guidance on drug price negotiations | N/A | |
| 2023-03-15 11:59 EST | News | Halozyme sees no impact on royalties after EU body revokes J&J's Darzalex patent | N/A | |
| 2023-02-26 10:52 EST | News | Halozyme Therapeutics: A Trailblazer, But With Lukewarm Financials | N/A | |
| 2023-02-22 00:56 EST | News | Halozyme Therapeutics Non-GAAP EPS of $0.48 beats by $0.01, revenue of $181.5M misses by $10.55M | N/A | |
| 2023-02-22 00:56 EST | News | Halozyme Therapeutics, Inc. (HALO) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-22 00:56 EST | News | Halozyme Therapeutics, Inc. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-02-20 22:26 EST | News | Halozyme Therapeutics Q4 2022 Earnings Preview | N/A | |
| 2023-01-10 23:05 EST | News | Halozyme issues 2023 revenue, adj. EPS guidance below estimates, shares fall ~7% | N/A | |
| 2023-01-10 07:28 EST | News | Halozyme Therapeutics: Chugging Along | N/A | |
| 2022-12-21 22:44 EST | News | Halozyme Therapeutics overweight at Morgan Stanley on Enhanze subcutaneous technology | N/A | |
| 2022-11-29 06:34 EST | News | Halozyme initiated Overweight at Wells Fargo on partnerships, patent moat | N/A | |
| 2022-11-22 21:07 EST | News | Argenx subcutaneous drug for neuromuscular disorder gets FDA priority review | N/A | |
| 2022-11-09 06:37 EST | News | Halozyme Therapeutics Non-GAAP EPS of $0.74 beats by $0.23, revenue of $208.98M beats by $17.81M | N/A | |
| 2022-11-09 06:37 EST | News | Halozyme Therapeutics, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-09 06:37 EST | News | Halozyme Therapeutics, Inc. (HALO) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-07 19:37 EST | News | Halozyme Therapeutics Q3 2022 Earnings Preview | N/A | |
| 2022-10-24 08:17 EST | News | Halozyme Therapeutics: A Pharma Mutual Fund In A Single Company | N/A | |
| 2022-10-24 08:17 EST | News | Halozyme Looks Good For Their Excellent Royalty Revenue Stream | N/A | |
| 2022-09-21 09:16 EST | News | Argenx files for US approval of subcutaneous form of neuromuscular disorder drug efgartigimod | N/A | |
| 2022-08-16 08:34 EST | News | Halozyme Therapeutics raises $625M through convertible senior notes due 2028 | N/A | |
| 2022-08-15 16:13 EST | News | Halozyme launches offering of $500M convertible senior notes | N/A | |
| 2022-08-15 16:12 EST | News | Hot Stocks: AXDX surges nearly 25%, EMBC gains on earnings, LI slides on mixed earnings, HALO also falls | N/A | |
| 2022-08-10 01:02 EST | News | Halozyme Therapeutics Non-GAAP EPS of $0.53, revenue of $152.37M; raises FY22 outlook | N/A | |
| 2022-08-10 01:02 EST | News | Shares of Halozyme add ~9% after hours on Q2 revenue rise, raised FY 2022 guidance | N/A | |
| 2022-08-10 01:02 EST | News | Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 03:16 EST | News | Halozyme Therapeutics Q2 Earnings Preview | N/A | |
| 2022-08-03 21:25 EST | News | Halozyme Therapeutics: One To Put On Your 'Shopping List' For The Next Market Sell-Off | N/A | |
| 2022-06-07 12:39 EST | News | Halozyme launches oral testosterone replace therapy Tlando | N/A | |
| 2022-05-26 12:54 EST | News | Antares wins full FDA approval for testosterone replacement therapy | N/A | |
| 2022-05-26 12:52 EST | News | Hot Stocks: Travel stocks rally; SRRA, ATRS jump on merger deals; NSTG plunges; BCYC extends low | N/A | |
| 2022-05-26 12:52 EST | News | Antares Pharma downgraded by Raymond James, 4 others after Halozyme ~$1B acquisition offer | N/A | |
| 2022-05-19 22:34 EST | News | Halozyme: Antares Pharma Bolsters Growth Prospects | N/A | |
| 2022-05-11 04:20 EST | News | Halozyme Therapeutics Non-GAAP EPS of $0.47 misses by $0.02, revenue of $117.3M misses by $10.95M | N/A | |
| 2022-05-11 04:20 EST | News | Halozyme Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-11 04:20 EST | News | Halozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 06:39 EST | News | Halozyme Therapeutics Q1 2022 Earnings Preview | N/A | |
| 2022-04-14 08:29 EST | News | Antares Pharma stock soars 49% on ~$1B acquisition deal by Halozyme | N/A | |
| 2022-04-13 18:14 EST | News | Antares Pharma stock soars 47% on ~$1B acquisition deal by Halozyme | N/A | |
| 2022-03-24 12:56 EST | News | Halozyme Therapeutics licenses ENHANZE drug delivery technology to Chugai | N/A | |
| 2022-03-23 03:07 EST | News | Argenx meets main goal in late-stage trial for subcutaneous myasthenia gravis candidate | N/A | |
| 2022-02-26 04:01 EST | News | Halozyme: Steady Revenue Growth At A Reasonable Valuation | N/A | |
| 2022-02-23 01:11 EST | News | Halozyme Therapeutics Non-GAAP EPS of $0.42 beats by $0.01, revenue of $102M beats by $2.31M | N/A | |
| 2022-02-23 01:11 EST | News | Halozyme Therapeutics, Inc.'s (HALO) CEO Helen Torley On Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-23 01:11 EST | News | Halozyme Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
About Halozyme Therapeutics, Inc (HALO):
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its proprietary product include Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company is also developing Perjeta for breast cancer; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ALXN1210 and ALXN1810 subcutaneous formulations; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; and Centre for the AIDS Programme of Research in South Africa. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
General
- Name Halozyme Therapeutics, Inc
- Symbol HALO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 136
- Fiscal Year EndDecember
- IPO Date2004-03-16
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.halozyme.com
View More
Valuation
- Trailing PE 47.84
- Forward PE 29.07
- Price/Sales (Trailing 12 Mt.) 23.28
- Price/Book (Most Recent Quarter) 39.44
- Enterprise Value Revenue 22.37
- Enterprise Value EBITDA 39.14
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $1.54
- Next Year EPS Estimate $2.63
- Next Quarter EPS Estimate $0.32
- Profit Margin 48%
- Operating Margin 54%
- Return on Assets 16%
- Return on Equity 106%
- Revenue 267.59 million
- Earnings Per Share $0.91
- Revenue Per Share $1.97
- Gross Profit 189.99 million
- Quarterly Earnings Growth 126.8%
View More
Highlights
- Market Capitalization 5.89 billion
- EBITDA 145.84 million
- PE Ratio 17.06
- PEG Ratio -2.5
- Analyst Target Price $47.82
- Book Value Per Share $1.12
View More
Share Statistics
- Shares Outstanding 135.28 million
- Shares Float 133.77 million
- % Held by Insiders 126%
- % Held by Institutions 102.75%
- Shares Short 12.42 million
- Shares Short Prior Month 14.43 million
- Short Ratio 7.48
- Short % of Float 10%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta 1.48
- 52 Week High $56.4
- 52 Week Low $14.59
- 50 Day Moving Average 46.6
- 200 Day Moving Average 38.42
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Halozyme Therapeutics, Inc (HALO) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Halozyme Therapeutics, Inc (HALO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-23 | $121.7 million | $0.50 | $0.54 | -7.42% |
| 2020-09-30 | 2020-11-02 | $N/A | $0.25 | $0.21 | 21.89% |
| 2020-06-30 | 2020-08-10 | $N/A | $0.19 | $0.25 | -22.83% |
| 2020-03-31 | 2020-05-11 | $25.35 million | -$0.04 | -$0.04 | -3.63% |
| 2019-12-31 | 2020-02-24 | $53.67 million | -$0.24 | -$0.14 | -67.6% |
| 2019-09-30 | 2019-11-12 | $46.23 million | -$0.17 | -$0.13 | -33.12% |
| 2019-06-30 | 2019-08-06 | $39.15 million | -$0.10 | -$0.15 | 33.73% |
| 2019-03-31 | 2019-05-07 | $56.95 million | $0.01 | $0.05 | -78.26% |
| 2018-12-31 | 2019-02-21 | $60.23 million | -$0.01 | -$0.03 | 60.16% |
| 2018-09-30 | 2018-11-06 | $25.56 million | -$0.19 | -$0.23 | 15.67% |
| 2018-06-30 | 2018-08-07 | $35.2 million | -$0.16 | -$0.22 | 25.65% |
| 2018-03-31 | 2018-05-10 | $30.87 million | -$0.19 | -$0.22 | 14.34% |
| 2017-12-31 | 2018-02-20 | $189.56 million | $0.85 | $0.77 | 11.05% |
| 2017-09-30 | 2017-11-07 | $63.73 million | $0.02 | -$0.11 | 118.18% |
| 2017-06-30 | 2017-08-08 | $33.75 million | -$0.23 | -$0.24 | 5.54% |
| 2017-03-31 | 2017-05-09 | $29.57 million | -$0.26 | -$0.24 | -6.34% |
| 2016-12-31 | 2017-02-28 | $39 million | -$0.21 | -$0.30 | 29.48% |
| 2016-09-30 | 2016-11-07 | $31.85 million | -$0.23 | -$0.26 | 13.04% |
| 2016-06-30 | 2016-08-09 | $33.34 million | -$0.21 | -$0.28 | 26.11% |
| 2016-03-31 | 2016-05-09 | $42.5 million | -$0.16 | -$0.22 | 26.84% |
| 2015-12-31 | 2016-02-29 | $52.23 million | $0.03 | -$0.03 | 199.01% |
| 2015-09-30 | 2015-11-09 | $20.78 million | -$0.19 | -$0.16 | -18.75% |
| 2015-06-30 | 2015-08-10 | $43.38 million | $0.02 | -$0.09 | 122.22% |
| 2015-03-31 | 2015-05-11 | $18.67 million | -$0.12 | -$0.13 | 7.69% |
| 2014-12-31 | 2015-03-02 | $30.38 million | -$0.04 | -$0.06 | 33.33% |
| 2014-09-30 | 2014-11-10 | $14.61 million | -$0.16 | -$0.14 | -14.29% |
| 2014-06-30 | 2014-08-11 | $18.39 million | -$0.13 | -$0.14 | 7.14% |
| 2014-03-31 | 2014-05-12 | $11.97 million | -$0.22 | -$0.14 | -57.14% |
| 2013-12-31 | 2014-02-27 | $12.5 million | -$0.19 | -$0.16 | -18.75% |
| 2013-09-30 | 2013-11-08 | $16.01 million | -$0.17 | -$0.15 | -13.33% |
| 2013-06-30 | 2013-08-07 | $14.45 million | -$0.20 | -$0.13 | -53.85% |
| 2013-03-31 | 2013-05-08 | $11.83 million | -$0.17 | -$0.15 | -13.33% |
| 2012-12-31 | 2013-02-25 | $21.79 million | -$0.04 | -$0.15 | 73.33% |
| 2012-09-30 | 2012-11-08 | $5.34 million | -$0.18 | -$0.14 | -28.57% |
| 2012-06-30 | 2012-08-06 | $7.76 million | -$0.13 | -$0.15 | 13.33% |
| 2012-03-31 | 2012-05-07 | $7.44 million | -$0.14 | -$0.11 | -27.27% |
| 2011-12-31 | 2012-03-09 | $2.41 million | -$0.18 | -$0.15 | -20% |
| 2011-09-30 | 2011-11-07 | $22.94 million | $0.05 | -$0.04 | 225% |
| 2011-06-30 | 2011-08-05 | $23.19 million | $0.03 | -$0.13 | 123.08% |
| 2011-03-31 | 2011-05-06 | $7.54 million | -$0.10 | -$0.12 | 16.67% |
| 2010-12-31 | 2011-03-11 | $3.57 million | -$0.17 | ||
| 2010-09-30 | 2010-11-05 | $3.4 million | -$0.13 | -$0.14 | 7.14% |
| 2010-06-30 | 2010-08-06 | $3.21 million | -$0.13 | -$0.14 | 7.14% |
| 2010-03-31 | 2010-05-07 | $3.44 million | -$0.13 | -$0.16 | 18.75% |
| 2009-12-31 | 2010-03-12 | $6.44 million | -$0.14 | -$0.17 | 17.65% |
| 2009-09-30 | 2009-11-06 | $3.03 million | -$0.16 | -$0.18 | 11.11% |
| 2009-06-30 | 2009-08-07 | $1.43 million | -$0.21 | -$0.17 | -23.53% |
| 2009-03-31 | 2009-05-08 | $2.77 million | -$0.18 | -$0.16 | -12.5% |
| 2008-12-31 | 2009-03-13 | $3.06 million | -$0.21 | -$0.13 | -61.54% |
| 2008-09-30 | 2008-11-06 | $2.46 million | -$0.14 | -$0.13 | -7.69% |
| 2008-06-30 | 2008-08-08 | $1.43 million | -$0.14 | -$0.13 | -7.69% |
| 2008-03-31 | 2008-05-08 | $1.81 million | -$0.13 | -$0.12 | -8.33% |
| 2007-12-31 | 2008-03-13 | $1.34 million | -$0.11 | -$0.08 | -37.5% |
| 2007-09-30 | 2007-11-08 | $943000 | -$0.09 | -$0.06 | -50% |
| 2007-06-30 | 2007-08-09 | $709000 | -$0.07 | -$0.04 | -75% |
| 2007-03-31 | 2007-05-10 | $810000 | -$0.05 | -$0.05 | 0% |
| 2006-12-31 | 2007-03-08 | $427000 | -$0.07 | -$0.06 | -16.67% |
| 2006-09-30 | 2006-11-09 | $362000 | -$0.06 | -$0.06 | 0% |
| 2006-06-30 | 2006-08-10 | $120000 | -$0.05 | -$0.05 | 0% |
| 2006-03-31 | 2006-05-10 | $73000 | -$0.06 | -$0.05 | -20% |
| 2005-12-31 | 2006-03-23 | $56000 | -$0.07 | -$0.06 | -16.67% |
| 2005-09-30 | 2005-11-11 | $25000 | -$0.07 | -$0.06 | -16.67% |
| 2005-06-30 | 2005-08-08 | $46000 | -$0.06 | -$0.06 | 0% |
| 2005-03-31 | 2005-05-13 | $N/A | -$0.06 | -$0.06 | 0% |
| 2004-12-31 | 2005-03-09 | $N/A | -$0.05 | -$0.07 | 28.57% |
| 2004-09-30 | 2004-11-12 | $N/A | -$0.08 | -$0.05 | -60% |
| 2004-06-30 | 2004-08-16 | $N/A | -$0.05 | -$0.04 | -25% |
| 2004-03-31 | 2004-06-01 | $N/A | -$0.08 | -$0.03 | -177.33% |
| 2003-12-31 | 2004-03-30 | $26000 | -$0.01 |
Halozyme Therapeutics, Inc (HALO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Halozyme Therapeutics, Inc (HALO) Chart:
Halozyme Therapeutics, Inc (HALO) News:
Below you will find a list of latest news for Halozyme Therapeutics, Inc (HALO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Halozyme Therapeutics, Inc (HALO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 20 | 0 | CALL | 0 | 0 | 186.03 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 0 | CALL | 0 | 0 | 169.68 | TRUE | 0 | 0 |
| 2024-05-17 | 25 | 0 | CALL | 0 | 0 | 142.39 | TRUE | 0 | 0 |
| 2024-05-17 | 30 | 0 | CALL | 0 | 0 | 96.04 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 4.5 | CALL | 0 | 3 | 40.17 | TRUE | 0 | 0 |
| 2024-05-17 | 40 | 1 | CALL | 4 | 1090 | 42.89 | FALSE | -0.25 | -0.2 |
| 2024-05-17 | 45 | 0.4 | CALL | 0 | 42 | 43.36 | FALSE | 0 | 0 |
| 2024-05-17 | 50 | 0.23 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 55 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 60 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 22.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 25 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 30 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 35 | 0.55 | PUT | 30 | 303 | 40.16 | FALSE | -0.2 | -0.27 |
| 2024-05-17 | 40 | 2.85 | PUT | 10 | 57 | 41.61 | TRUE | 0.1 | 0.04 |
| 2024-05-17 | 45 | 6.5 | PUT | 0 | 4 | 53.83 | TRUE | 0 | 0 |
| 2024-05-17 | 50 | 0 | PUT | 0 | 0 | 121.17 | TRUE | 0 | 0 |
| 2024-05-17 | 55 | 0 | PUT | 0 | 0 | 110.94 | TRUE | 0 | 0 |
| 2024-05-17 | 60 | 0 | PUT | 0 | 0 | 115.44 | TRUE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | CALL | 0 | 0 | 144.22 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 0 | CALL | 0 | 0 | 131.69 | TRUE | 0 | 0 |
| 2024-06-21 | 22.5 | 18.35 | CALL | 0 | 2 | 97.76 | TRUE | 0 | 0 |
| 2024-06-21 | 25 | 0 | CALL | 0 | 0 | 94.64 | TRUE | 0 | 0 |
| 2024-06-21 | 30 | 8.7 | CALL | 1 | 15 | 56.07 | TRUE | -0.2 | -0.02 |
| 2024-06-21 | 35 | 7.67 | CALL | 0 | 137 | 40.23 | TRUE | 0 | 0 |
| 2024-06-21 | 40 | 2.31 | CALL | 0 | 372 | 38.64 | FALSE | 0 | 0 |
| 2024-06-21 | 45 | 0.84 | CALL | 0 | 554 | 38.09 | FALSE | 0 | 0 |
| 2024-06-21 | 50 | 0.48 | CALL | 0 | 30 | 40.9 | FALSE | 0 | 0 |
| 2024-06-21 | 55 | 0.2 | CALL | 0 | 69 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 60 | 0.35 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 22.5 | 0.25 | PUT | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 25 | 0.21 | PUT | 0 | 51 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 30 | 0.32 | PUT | 0 | 89 | 45.24 | FALSE | 0 | 0 |
| 2024-06-21 | 35 | 1.15 | PUT | 2 | 98 | 39.8 | FALSE | -0.1 | -0.08 |
| 2024-06-21 | 40 | 2.35 | PUT | 0 | 6 | 38.84 | TRUE | 0 | 0 |
| 2024-06-21 | 45 | 5.97 | PUT | 0 | 2 | 28.8 | TRUE | 0 | 0 |
| 2024-06-21 | 50 | 10.1 | PUT | 0 | 57 | 55.99 | TRUE | 0 | 0 |
| 2024-06-21 | 55 | 0 | PUT | 0 | 0 | 63.11 | TRUE | 0 | 0 |
| 2024-06-21 | 60 | 0 | PUT | 0 | 0 | 88.8 | TRUE | 0 | 0 |
| 2024-09-20 | 17.5 | 0 | CALL | 0 | 0 | 90.44 | TRUE | 0 | 0 |
| 2024-09-20 | 20 | 0 | CALL | 0 | 0 | 83.67 | TRUE | 0 | 0 |
| 2024-09-20 | 22.5 | 0 | CALL | 0 | 0 | 71.21 | TRUE | 0 | 0 |
| 2024-09-20 | 25 | 0 | CALL | 0 | 0 | 68.98 | TRUE | 0 | 0 |
| 2024-09-20 | 30 | 0 | CALL | 0 | 0 | 53.59 | TRUE | 0 | 0 |
| 2024-09-20 | 35 | 5.9 | CALL | 1 | 25 | 41.21 | TRUE | 5.9 | 0 |
| 2024-09-20 | 40 | 4.09 | CALL | 0 | 17 | 38.81 | FALSE | 0 | 0 |
| 2024-09-20 | 45 | 1.69 | CALL | 1 | 22 | 38.37 | FALSE | 1.69 | 0 |
| 2024-09-20 | 50 | 0.86 | CALL | 0 | 71 | 35.73 | FALSE | 0 | 0 |
| 2024-09-20 | 55 | 1.25 | CALL | 0 | 10 | 37.78 | FALSE | 0 | 0 |
| 2024-09-20 | 60 | 0.19 | CALL | 0 | 0 | 40.72 | FALSE | 0 | 0 |
| 2024-09-20 | 17.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 22.5 | 0.66 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 25 | 0 | PUT | 0 | 0 | 57.42 | FALSE | 0 | 0 |
| 2024-09-20 | 30 | 0.9 | PUT | 0 | 30 | 41.21 | FALSE | 0 | 0 |
| 2024-09-20 | 35 | 2.18 | PUT | 6 | 5 | 39.36 | FALSE | 2.18 | 0 |
| 2024-09-20 | 40 | 4.2 | PUT | 0 | 18 | 37.29 | TRUE | 0 | 0 |
| 2024-09-20 | 45 | 0 | PUT | 0 | 0 | 34.26 | TRUE | 0 | 0 |
| 2024-09-20 | 50 | 0 | PUT | 0 | 0 | 47.31 | TRUE | 0 | 0 |
| 2024-09-20 | 55 | 0 | PUT | 0 | 0 | 53.76 | TRUE | 0 | 0 |
| 2024-09-20 | 60 | 0 | PUT | 0 | 0 | 56.86 | TRUE | 0 | 0 |
| 2024-12-20 | 17.5 | 24.8 | CALL | 0 | 16 | 78 | TRUE | 0 | 0 |
| 2024-12-20 | 20 | 15.93 | CALL | 0 | 13 | 72.03 | TRUE | 0 | 0 |
| 2024-12-20 | 22.5 | 0 | CALL | 0 | 0 | 63 | TRUE | 0 | 0 |
| 2024-12-20 | 25 | 16.8 | CALL | 0 | 27 | 55.58 | TRUE | 0 | 0 |
| 2024-12-20 | 30 | 10.6 | CALL | 15 | 28 | 45.9 | TRUE | 10.6 | 0 |
| 2024-12-20 | 35 | 7.9 | CALL | 0 | 132 | 41.32 | TRUE | 0 | 0 |
| 2024-12-20 | 40 | 5.4 | CALL | 0 | 896 | 39.63 | FALSE | 0 | 0 |
| 2024-12-20 | 45 | 2.85 | CALL | 0 | 680 | 37.31 | FALSE | 0 | 0 |
| 2024-12-20 | 50 | 1.55 | CALL | 1 | 625 | 37.12 | FALSE | 1.55 | 0 |
| 2024-12-20 | 55 | 1.05 | CALL | 0 | 32 | 35.76 | FALSE | 0 | 0 |
| 2024-12-20 | 60 | 0.55 | CALL | 0 | 36 | 41.23 | FALSE | 0 | 0 |
| 2024-12-20 | 17.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 20 | 0.6 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 22.5 | 0.75 | PUT | 0 | 1 | 56.65 | FALSE | 0 | 0 |
| 2024-12-20 | 25 | 0.62 | PUT | 0 | 2 | 43.26 | FALSE | 0 | 0 |
| 2024-12-20 | 30 | 1.25 | PUT | 0 | 46 | 42.07 | FALSE | 0 | 0 |
| 2024-12-20 | 35 | 2.53 | PUT | 0 | 72 | 39.2 | FALSE | 0 | 0 |
| 2024-12-20 | 40 | 4.5 | PUT | 0 | 10 | 37.95 | TRUE | 0 | 0 |
| 2024-12-20 | 45 | 11.42 | PUT | 0 | 79 | 38.75 | TRUE | 0 | 0 |
| 2024-12-20 | 50 | 11.16 | PUT | 0 | 128 | 42.1 | TRUE | 0 | 0 |
| 2024-12-20 | 55 | 0 | PUT | 0 | 0 | 46.04 | TRUE | 0 | 0 |
| 2024-12-20 | 60 | 0 | PUT | 0 | 0 | 51.59 | TRUE | 0 | 0 |
| 2025-03-21 | 20 | 0 | CALL | 0 | 0 | 60.36 | TRUE | 0 | 0 |
| 2025-03-21 | 22.5 | 0 | CALL | 0 | 0 | 58.29 | TRUE | 0 | 0 |
| 2025-03-21 | 25 | 0 | CALL | 0 | 0 | 50.36 | TRUE | 0 | 0 |
| 2025-03-21 | 30 | 13.52 | CALL | 0 | 7 | 41.6 | TRUE | 0 | 0 |
| 2025-03-21 | 35 | 0 | CALL | 0 | 0 | 43.55 | TRUE | 0 | 0 |
| 2025-03-21 | 40 | 6.5 | CALL | 0 | 130 | 38.63 | FALSE | 0 | 0 |
| 2025-03-21 | 45 | 4.1 | CALL | 0 | 430 | 35.5 | FALSE | 0 | 0 |
| 2025-03-21 | 50 | 2.4 | CALL | 1 | 3 | 37.55 | FALSE | 2.4 | 0 |
| 2025-03-21 | 55 | 1.6 | CALL | 1 | 0 | 37.68 | FALSE | 1.6 | 0 |
| 2025-03-21 | 60 | 1 | CALL | 1 | 6 | 37.1 | FALSE | 1 | 0 |
| 2025-03-21 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 22.5 | 0 | PUT | 0 | 0 | 53.3 | FALSE | 0 | 0 |
| 2025-03-21 | 25 | 0 | PUT | 0 | 0 | 44.66 | FALSE | 0 | 0 |
| 2025-03-21 | 30 | 1.65 | PUT | 0 | 25 | 41.88 | FALSE | 0 | 0 |
| 2025-03-21 | 35 | 0 | PUT | 0 | 1 | 37.63 | FALSE | 0 | 0 |
| 2025-03-21 | 40 | 0 | PUT | 0 | 0 | 36.39 | TRUE | 0 | 0 |
| 2025-03-21 | 45 | 0 | PUT | 0 | 0 | 41.33 | TRUE | 0 | 0 |
| 2025-03-21 | 50 | 0 | PUT | 0 | 0 | 32.39 | TRUE | 0 | 0 |
| 2025-03-21 | 55 | 0 | PUT | 0 | 0 | 41.98 | TRUE | 0 | 0 |
| 2025-03-21 | 60 | 0 | PUT | 0 | 0 | 40.8 | TRUE | 0 | 0 |
Latest HALO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 49 | $43.1 |
| Jun 13, 2022 7:59 PM EST | 66 | $43.1 |
| Jun 13, 2022 7:59 PM EST | 49 | $43.1 |
| Jun 13, 2022 7:59 PM EST | 200 | $43.1 |
| Jun 13, 2022 7:59 PM EST | 200 | $43.1 |
Halozyme Therapeutics, Inc (HALO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020006544/0001179110-20-006544-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000021545719004072/0000215457-19-004072-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000083423720008702/0000834237-20-008702-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000093247119005265/0000932471-19-005265-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000103342719000019/0001033427-19-000019-index.htm |
| 2020-01-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000103342720000010/0001033427-20-000010-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000110465919052329/0001104659-19-052329-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000110465920013287/0001104659-20-013287-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000110465920013317/0001104659-20-013317-index.htm |
| 2018-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm |
| 2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm |
| 2018-08-16 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1159036/000114036118036549/0001140361-18-036549-index.htm |
| 2018-08-28 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1159036/000114036118037161/0001140361-18-037161-index.htm |
| 2019-06-07 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1159036/000114036119010688/0001140361-19-010688-index.htm |
| 2019-07-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1159036/000114036119012431/0001140361-19-012431-index.htm |
| 2019-11-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1159036/000114036119019841/0001140361-19-019841-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903618000036/0001159036-18-000036-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1159036/000115903618000037/0001159036-18-000037-index.htm |
| 2018-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903618000039/0001159036-18-000039-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903618000042/0001159036-18-000042-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1159036/000115903618000043/0001159036-18-000043-index.htm |
| 2018-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903618000045/0001159036-18-000045-index.htm |
| 2019-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000002/0001159036-19-000002-index.htm |
| 2019-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000005/0001159036-19-000005-index.htm |
| 2019-02-21 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000006/0001159036-19-000006-index.htm |
| 2019-03-01 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000009/0001159036-19-000009-index.htm |
| 2019-03-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000013/0001159036-19-000013-index.htm |
| 2019-03-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000014/0001159036-19-000014-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000019/0001159036-19-000019-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000026/0001159036-19-000026-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000027/0001159036-19-000027-index.htm |
| 2019-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000030/0001159036-19-000030-index.htm |
| 2019-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000031/0001159036-19-000031-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000043/0001159036-19-000043-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000044/0001159036-19-000044-index.htm |
| 2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000046/0001159036-19-000046-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000049/0001159036-19-000049-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000058/0001159036-19-000058-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000060/0001159036-19-000060-index.htm |
| 2019-11-12 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903619000061/0001159036-19-000061-index.htm |
| 2020-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000002/0001159036-20-000002-index.htm |
| 2020-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000004/0001159036-20-000004-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000011/0001159036-20-000011-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000012/0001159036-20-000012-index.htm |
| 2020-02-24 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000013/0001159036-20-000013-index.htm |
| 2020-03-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000018/0001159036-20-000018-index.htm |
| 2020-03-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000019/0001159036-20-000019-index.htm |
| 2020-04-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000022/0001159036-20-000022-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000024/0001159036-20-000024-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000029/0001159036-20-000029-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000030/0001159036-20-000030-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000036/0001159036-20-000036-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000037/0001159036-20-000037-index.htm |
| 2020-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000043/0001159036-20-000043-index.htm |
| 2020-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1159036/000115903620000044/0001159036-20-000044-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911018008700/0001179110-18-008700-index.htm |
| 2018-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911018010332/0001179110-18-010332-index.htm |
| 2018-09-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911018011302/0001179110-18-011302-index.htm |
| 2018-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911018011307/0001179110-18-011307-index.htm |
| 2018-09-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911018011416/0001179110-18-011416-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911018012004/0001179110-18-012004-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911018013625/0001179110-18-013625-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001315/0001179110-19-001315-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001316/0001179110-19-001316-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001318/0001179110-19-001318-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001321/0001179110-19-001321-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001452/0001179110-19-001452-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001931/0001179110-19-001931-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001932/0001179110-19-001932-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001933/0001179110-19-001933-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001934/0001179110-19-001934-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001935/0001179110-19-001935-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002004/0001179110-19-002004-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002005/0001179110-19-002005-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002006/0001179110-19-002006-index.htm |
| 2019-02-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002007/0001179110-19-002007-index.htm |
| 2019-02-20 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002193/0001179110-19-002193-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002462/0001179110-19-002462-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002463/0001179110-19-002463-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002464/0001179110-19-002464-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002465/0001179110-19-002465-index.htm |
| 2019-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019004936/0001179110-19-004936-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005497/0001179110-19-005497-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005499/0001179110-19-005499-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005501/0001179110-19-005501-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005504/0001179110-19-005504-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005506/0001179110-19-005506-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005508/0001179110-19-005508-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005511/0001179110-19-005511-index.htm |
| 2019-05-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005597/0001179110-19-005597-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019007033/0001179110-19-007033-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019007125/0001179110-19-007125-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019007734/0001179110-19-007734-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911019009165/0001179110-19-009165-index.htm |
| 2020-01-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000294/0001179110-20-000294-index.htm |
| 2020-01-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000298/0001179110-20-000298-index.htm |
| 2020-02-04 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000982/0001179110-20-000982-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000987/0001179110-20-000987-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000989/0001179110-20-000989-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000992/0001179110-20-000992-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001532/0001179110-20-001532-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001533/0001179110-20-001533-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001535/0001179110-20-001535-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001536/0001179110-20-001536-index.htm |
| 2020-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001579/0001179110-20-001579-index.htm |
| 2020-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001581/0001179110-20-001581-index.htm |
| 2020-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001582/0001179110-20-001582-index.htm |
| 2020-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001583/0001179110-20-001583-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001748/0001179110-20-001748-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001749/0001179110-20-001749-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001750/0001179110-20-001750-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020002174/0001179110-20-002174-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020002175/0001179110-20-002175-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020002177/0001179110-20-002177-index.htm |
| 2020-03-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020003046/0001179110-20-003046-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020003052/0001179110-20-003052-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/0001179110-20-003999-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020004645/0001179110-20-004645-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005375/0001179110-20-005375-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005376/0001179110-20-005376-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005377/0001179110-20-005377-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005378/0001179110-20-005378-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005379/0001179110-20-005379-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005380/0001179110-20-005380-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005382/0001179110-20-005382-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020006427/0001179110-20-006427-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020006544/0001179110-20-006544-index.htm |
| 2020-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020008379/0001179110-20-008379-index.htm |
| 2020-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009018/0001179110-20-009018-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009047/0001179110-20-009047-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009192/0001179110-20-009192-index.htm |
| 2020-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009605/0001179110-20-009605-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009727/0001179110-20-009727-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009905/0001179110-20-009905-index.htm |
| 2020-10-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000117911020010606/0001179110-20-010606-index.htm |
| 2018-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000119312518266637/0001193125-18-266637-index.htm |
| 2018-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000119312518334014/0001193125-18-334014-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000119312519037877/0001193125-19-037877-index.htm |
| 2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000119312519171015/0001193125-19-171015-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000119312519289955/0001193125-19-289955-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000119312519291625/0001193125-19-291625-index.htm |
| 2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1159036/000119312519294791/0001193125-19-294791-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000119312520037814/0001193125-20-037814-index.htm |
| 2018-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm |
| 2018-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm |
| 2018-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm |
| 2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm |
| 2020-04-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1159036/000168386320002633/0001683863-20-002633-index.htm |
| 2018-12-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1159036/999999999718009618/9999999997-18-009618-index.htm |
Halozyme Therapeutics, Inc (HALO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Halozyme Therapeutics, Inc (HALO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 126%Institutional Ownership: 10275%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-02-03 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 23,119.00 | 105,081.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000989/0001179110-20-000989-index.htm | ||
| 2020-02-12 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 11,262.00 | 108,068.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001581/0001179110-20-001581-index.htm | ||
| 2020-02-14 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 7,809.00 | 111,983.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001749/0001179110-20-001749-index.htm | ||
| 2019-05-02 | Matthew L. Posard | Director | Buy | 12,173.00 | 114,924.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005511/0001179110-19-005511-index.htm | ||
| 2020-02-22 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 11,392.00 | 120,675.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020002175/0001179110-20-002175-index.htm | ||
| 2020-04-30 | Matthew L. Posard | Director | Buy | 8,829.00 | 123,753.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005382/0001179110-20-005382-index.htm | ||
| 2020-09-04 | Masaru Matsuda | SVP, General Counsel | Buy | 6,884.00 | 13,822.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009605/0001179110-20-009605-index.htm | ||
| 2020-10-20 | Michael J. LaBarre | SVP, Chief Technical Officer | Sell | 12,000.00 | 30.43 | 365,148.00 | 146,800.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020010606/0001179110-20-010606-index.htm |
| 2020-09-21 | Michael J. LaBarre | SVP, Chief Technical Officer | Sell | 12,000.00 | 26.91 | 322,884.00 | 158,800.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009905/0001179110-20-009905-index.htm |
| 2020-02-03 | Michael J. LaBarre | SVP, Chief Technical Officer | Buy | 11,559.00 | 165,782.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000992/0001179110-20-000992-index.htm | ||
| 2020-02-12 | Michael J. LaBarre | SVP, Chief Technical Officer | Buy | 7,883.00 | 169,376.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001582/0001179110-20-001582-index.htm | ||
| 2020-08-20 | Michael J. LaBarre | SVP, Chief Technical Officer | Sell | 12,000.00 | 28.30 | 339,564.00 | 170,800.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009192/0001179110-20-009192-index.htm |
| 2020-02-14 | Michael J. LaBarre | SVP, Chief Technical Officer | Buy | 5,772.00 | 172,423.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001750/0001179110-20-001750-index.htm | ||
| 2020-05-20 | Michael J. LaBarre | SVP, Chief Technical Officer | Sell | 21,387.00 | 23.80 | 509,074.76 | 176,187.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020006427/0001179110-20-006427-index.htm |
| 2020-02-22 | Michael J. LaBarre | SVP, Chief Technical Officer | Buy | 8,803.00 | 179,231.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020002177/0001179110-20-002177-index.htm | ||
| 2019-05-02 | Bernadette Connaughton | Director | Buy | 12,173.00 | 17,954.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005499/0001179110-19-005499-index.htm | ||
| 2020-07-20 | Michael J. LaBarre | SVP, Chief Technical Officer | Sell | 12,000.00 | 29.01 | 348,072.00 | 182,800.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020008379/0001179110-20-008379-index.htm |
| 2018-08-28 | RANDAL J KIRK | 10% Share Holder | Sell | 256,860.00 | 18.02 | 4,628,617.20 | 1,897,610.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm |
| 2020-05-22 | Michael J. LaBarre | SVP, Chief Technical Officer | Buy | 18,613.00 | 7.14 | 132,896.82 | 194,800.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020006544/0001179110-20-006544-index.htm |
| 2020-05-20 | Michael J. LaBarre | SVP, Chief Technical Officer | Buy | 21,387.00 | 7.14 | 152,703.18 | 197,574.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020006427/0001179110-20-006427-index.htm |
| 2019-10-01 | Benjamin Hickey | SVP, Chief Commerical Officer | Buy | 20,216.00 | 20,216.00 | https://www.sec.gov/Archives/edgar/data/1159036/000110465919052329/0001104659-19-052329-index.htm | ||
| 2018-08-27 | RANDAL J KIRK | 10% Share Holder | Sell | 64,996.00 | 18.22 | 1,184,227.12 | 2,154,470.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm |
| 2020-09-11 | CONNIE MATSUI | Director | Sell | 32,000.00 | 27.06 | 865,792.00 | 216,753.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009727/0001179110-20-009727-index.htm |
| 2018-08-24 | RANDAL J KIRK | 10% Share Holder | Sell | 61,428.00 | 18.20 | 1,117,989.60 | 2,219,466.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm |
| 2019-05-02 | Kenneth J Kelley | Director | Buy | 12,173.00 | 224,924.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005506/0001179110-19-005506-index.htm | ||
| 2018-08-23 | RANDAL J KIRK | 10% Share Holder | Sell | 149,353.00 | 18.48 | 2,760,043.44 | 2,280,894.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm |
| 2019-05-02 | CONNIE MATSUI | Director | Buy | 12,173.00 | 239,924.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005508/0001179110-19-005508-index.htm | ||
| 2020-03-19 | Kenneth J Kelley | Director | Buy | 17,543.00 | 14.19 | 248,933.42 | 242,467.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/0001179110-20-003999-index.htm |
| 2018-08-22 | RANDAL J KIRK | 10% Share Holder | Sell | 464,624.00 | 17.49 | 8,126,273.76 | 2,430,247.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm |
| 2020-04-30 | CONNIE MATSUI | Director | Buy | 8,829.00 | 248,753.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005380/0001179110-20-005380-index.htm | ||
| 2020-03-19 | Kenneth J Kelley | Director | Buy | 17,543.00 | 14.25 | 249,982.49 | 260,010.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/0001179110-20-003999-index.htm |
| 2020-04-30 | Bernadette Connaughton | Director | Buy | 8,829.00 | 26,783.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005376/0001179110-20-005376-index.htm | ||
| 2020-03-19 | Kenneth J Kelley | Director | Buy | 17,543.00 | 14.24 | 249,780.74 | 277,553.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/0001179110-20-003999-index.htm |
| 2020-04-30 | Kenneth J Kelley | Director | Buy | 8,829.00 | 286,382.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005379/0001179110-20-005379-index.htm | ||
| 2018-08-21 | RANDAL J KIRK | 10% Share Holder | Sell | 95,819.00 | 17.15 | 1,643,295.85 | 2,894,871.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm |
| 2018-08-16 | RANDAL J KIRK | 10% Share Holder | Sell | 56,668.00 | 17.24 | 976,956.32 | 2,985,054.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm |
| 2018-08-15 | RANDAL J KIRK | 10% Share Holder | Sell | 54,397.00 | 17.15 | 932,908.55 | 3,041,722.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm |
| 2018-08-14 | RANDAL J KIRK | 10% Share Holder | Sell | 180,154.00 | 17.36 | 3,127,473.44 | 3,096,119.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm |
| 2020-08-13 | James M Daly | Director | Sell | 34,337.00 | 29.12 | 999,893.44 | 31,365.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020009018/0001179110-20-009018-index.htm |
| 2018-08-10 | RANDAL J KIRK | 10% Share Holder | Sell | 120,606.00 | 17.08 | 2,059,950.48 | 3,276,273.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm |
| 2018-08-09 | RANDAL J KIRK | 10% Share Holder | Sell | 132,591.00 | 17.48 | 2,317,690.68 | 3,396,879.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm |
| 2018-08-08 | RANDAL J KIRK | 10% Share Holder | Sell | 87,185.00 | 17.52 | 1,527,481.20 | 3,529,470.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm |
| 2018-07-27 | RANDAL J KIRK | 10% Share Holder | Sell | 29,074.00 | 16.90 | 491,350.60 | 3,616,655.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm |
| 2018-07-26 | RANDAL J KIRK | 10% Share Holder | Sell | 89,136.00 | 17.30 | 1,542,052.80 | 3,645,729.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm |
| 2018-07-25 | RANDAL J KIRK | 10% Share Holder | Sell | 61,741.00 | 17.32 | 1,069,354.12 | 3,734,865.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm |
| 2018-06-29 | RANDAL J KIRK | 10% Share Holder | Sell | 72,753.00 | 16.97 | 1,234,618.41 | 3,796,606.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm |
| 2019-02-14 | Dimitrios Chondros | SVP, Chief Medical Officer | Buy | 6,790.00 | 38,389.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002007/0001179110-19-002007-index.htm | ||
| 2019-02-03 | Helen Torley | President and CEO | Buy | 55,487.00 | 384,973.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001315/0001179110-19-001315-index.htm | ||
| 2019-08-03 | Dimitrios Chondros | SVP, Chief Medical Officer | Sell | 1,328.00 | 16.70 | 22,177.60 | 38,584.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019009165/0001179110-19-009165-index.htm |
| 2018-06-28 | RANDAL J KIRK | 10% Share Holder | Sell | 76,291.00 | 16.99 | 1,296,184.09 | 3,869,359.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm |
| 2018-08-28 | RANDAL J KIRK | 10% Share Holder | Sell | 175,389.00 | 18.02 | 3,160,509.78 | 3,900,919.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm |
| 2018-06-27 | RANDAL J KIRK | 10% Share Holder | Sell | 31,795.00 | 17.34 | 551,325.30 | 3,945,650.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm |
| 2019-02-06 | Helen Torley | President and CEO | Buy | 31,250.00 | 396,798.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001452/0001179110-19-001452-index.htm | ||
| 2019-02-22 | Dimitrios Chondros | SVP, Chief Medical Officer | Buy | 3,884.00 | 39,918.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002465/0001179110-19-002465-index.htm | ||
| 2019-06-01 | Dimitrios Chondros | SVP, Chief Medical Officer | Buy | 2,043.00 | 40,618.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019007033/0001179110-19-007033-index.htm | ||
| 2018-08-27 | RANDAL J KIRK | 10% Share Holder | Sell | 44,381.00 | 18.22 | 808,621.82 | 4,076,308.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm |
| 2019-02-14 | Helen Torley | President and CEO | Buy | 28,730.00 | 410,981.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002004/0001179110-19-002004-index.htm | ||
| 2018-08-24 | RANDAL J KIRK | 10% Share Holder | Sell | 41,944.00 | 18.20 | 763,380.80 | 4,120,689.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm |
| 2018-08-23 | RANDAL J KIRK | 10% Share Holder | Sell | 101,982.00 | 18.48 | 1,884,627.36 | 4,162,633.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm |
| 2018-08-22 | RANDAL J KIRK | 10% Share Holder | Sell | 317,257.00 | 17.49 | 5,548,824.93 | 4,264,615.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm |
| 2019-02-22 | Helen Torley | President and CEO | Buy | 39,354.00 | 436,091.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002462/0001179110-19-002462-index.htm | ||
| 2018-08-21 | RANDAL J KIRK | 10% Share Holder | Sell | 65,427.00 | 17.15 | 1,122,073.05 | 4,581,872.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm |
| 2020-02-03 | Helen Torley | President and CEO | Buy | 55,487.00 | 459,567.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020000987/0001179110-20-000987-index.htm | ||
| 2018-08-16 | RANDAL J KIRK | 10% Share Holder | Sell | 38,695.00 | 17.24 | 667,101.80 | 4,643,451.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm |
| 2018-08-15 | RANDAL J KIRK | 10% Share Holder | Sell | 37,144.00 | 17.15 | 637,019.60 | 4,682,146.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm |
| 2018-08-14 | RANDAL J KIRK | 10% Share Holder | Sell | 123,014.00 | 17.36 | 2,135,523.04 | 4,719,290.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm |
| 2020-02-12 | Helen Torley | President and CEO | Buy | 32,795.00 | 472,452.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001579/0001179110-20-001579-index.htm | ||
| 2018-08-10 | RANDAL J KIRK | 10% Share Holder | Sell | 82,353.00 | 17.08 | 1,406,589.24 | 4,842,304.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm |
| 2020-02-14 | Helen Torley | President and CEO | Buy | 28,730.00 | 484,923.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001748/0001179110-20-001748-index.htm | ||
| 2018-08-09 | RANDAL J KIRK | 10% Share Holder | Sell | 90,536.00 | 17.48 | 1,582,569.28 | 4,924,657.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm |
| 2018-08-08 | RANDAL J KIRK | 10% Share Holder | Sell | 59,533.00 | 17.52 | 1,043,018.16 | 5,015,193.00 | https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm |
| 2018-07-27 | RANDAL J KIRK | 10% Share Holder | Sell | 19,853.00 | 16.90 | 335,515.70 | 5,074,726.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm |
| 2018-07-26 | RANDAL J KIRK | 10% Share Holder | Sell | 60,864.00 | 17.30 | 1,052,947.20 | 5,094,579.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm |
| 2020-02-22 | Helen Torley | President and CEO | Buy | 39,354.00 | 510,033.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020002174/0001179110-20-002174-index.htm | ||
| 2018-07-25 | RANDAL J KIRK | 10% Share Holder | Sell | 42,159.00 | 17.32 | 730,193.88 | 5,155,443.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm |
| 2018-06-29 | RANDAL J KIRK | 10% Share Holder | Sell | 49,678.00 | 16.97 | 843,035.66 | 5,197,602.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm |
| 2018-06-28 | RANDAL J KIRK | 10% Share Holder | Sell | 52,094.00 | 16.99 | 885,077.06 | 5,247,280.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm |
| 2018-06-27 | RANDAL J KIRK | 10% Share Holder | Sell | 21,710.00 | 17.34 | 376,451.40 | 5,299,374.00 | https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm |
| 2018-06-15 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 6,875.00 | 54,385.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911018008700/0001179110-18-008700-index.htm | ||
| 2019-02-03 | HARRY J LEONHARDT | SVP, GC | Buy | 15,413.00 | 54,971.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001318/0001179110-19-001318-index.htm | ||
| 2019-05-02 | James M Daly | Director | Buy | 12,173.00 | 56,873.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005501/0001179110-19-005501-index.htm | ||
| 2019-02-14 | HARRY J LEONHARDT | SVP, GC | Buy | 7,809.00 | 57,122.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002006/0001179110-19-002006-index.htm | ||
| 2018-09-07 | Bernadette Connaughton | Director | Buy | 5,781.00 | 5,781.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911018011307/0001179110-18-011307-index.htm | ||
| 2019-05-02 | Jeffrey William Henderson | Director | Buy | 12,173.00 | 63,278.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005504/0001179110-19-005504-index.htm | ||
| 2020-04-30 | James M Daly | Director | Buy | 8,829.00 | 65,702.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005377/0001179110-20-005377-index.htm | ||
| 2019-02-22 | HARRY J LEONHARDT | SVP, GC | Buy | 11,392.00 | 65,814.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002464/0001179110-19-002464-index.htm | ||
| 2019-04-13 | HARRY J LEONHARDT | SVP, GC | Buy | 6,875.00 | 68,750.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019004936/0001179110-19-004936-index.htm | ||
| 2020-04-30 | Jeffrey William Henderson | Director | Buy | 8,829.00 | 72,107.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005378/0001179110-20-005378-index.htm | ||
| 2019-05-02 | JEAN-PIERRE BIZZARI | Director | Buy | 12,173.00 | 73,485.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019005497/0001179110-19-005497-index.htm | ||
| 2019-02-14 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 7,809.00 | 73,742.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002005/0001179110-19-002005-index.htm | ||
| 2019-02-03 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 23,119.00 | 74,250.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019001316/0001179110-19-001316-index.htm | ||
| 2020-04-30 | JEAN-PIERRE BIZZARI | Director | Buy | 8,829.00 | 82,314.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020005375/0001179110-20-005375-index.htm | ||
| 2019-02-22 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 11,392.00 | 82,434.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019002463/0001179110-19-002463-index.htm | ||
| 2019-06-15 | Laurie Stelzer | SVP, Chief Financial Officer | Buy | 6,875.00 | 85,370.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911019007734/0001179110-19-007734-index.htm | ||
| 2020-02-12 | Masaru Matsuda | SVP, General Counsel | Buy | 4,130.00 | 8,619.00 | https://www.sec.gov/Archives/edgar/data/1159036/000117911020001583/0001179110-20-001583-index.htm |